YQYuyan Qian

Yuyan Qian

*This is an algorithmically generated author record based on publicly available information.

Yuyan Qian has a total of 19 co-authors. Here are the top co-authors by number of shared publications:

  • Yong Hu

    Department of Polymeric Materials, School of Materials Science and Engineering, Tongji University, Shanghai, China

    4 shared publications
  • Yu Fan

    Department of Polymeric Materials, School of Materials Science and Engineering, Tongji University, Shanghai 201804, People's Republic of China

    3 shared publications
  • Beibei Zhang

    Department of Polymeric Materials, School of Materials Science and Engineering, Tongji University, 4800 Caoan Road, Shanghai 201804, China

    2 shared publications
  • Jianzhong Du

    East China University of Science and Technology

    2 shared publications
  • Yao Xu

    Department of Polymeric Materials School of Materials Science and Engineering Tongji University Shanghai China

    2 shared publications
  • Dong Li

    Department of Laboratory Medicine Shanghai Tongji Hospital School of Medicine Tongji University Shanghai 200065 China

    1 shared publication

Latest Publications

  • Double-Layer Nucleoside-Microneedles Co-Delivering Dexamethasone Vesicles and Adenosine Overcome Pseudomembrane Barriers for the Treatment of Oral Ulcer

    by Beibei Zhang, Yuyan Qian, Jianhua Li, Yu Fan, Mingyuan Gao, Qianqian Wu, Zhouxiang Li, Yong Hu, Jianzhong Du

    Oral ulcers are common, painful mucosal lesions that significantly impair patients' quality of life. The dynamic and moist oral environment, pseudomembrane formation, and limitations of corticosteroid therapies present ongoing clinical challenges. To address these important challenges, we developed double-layer microneedles integrating three functional components: a rapidly dissolving poly(vinyl alcohol) (PVA) substrate for immediate mucosal adhesion, nucleoside-based microneedles for pseudomembrane penetration and oxidative stress relief, and dexamethasone-loaded polymer vesicles (Dex-PVs). The vesicle improves the bioavailability of dexamethasone and enables a slow, sustained release, enhancing its therapeutic effects. Nucleoside microneedles, incorporating adenosine, synergistically enhance anti-inflammatory and analgesic effects by reducing the release of inflammatory cytokines and decreasing neuronal excitability and reverse the glucocorticoid-induced inhibition of cell migration by promoting CD31 and Ki67 expression. In vivo experiments confirmed that the microneedle reduced the ulcer area to 6.3% after 9 days of treatment (a 69.3% reduction compared to commercial formulations), with significant analgesic effects. This multiscale engineering approach addresses key challenges in oral drug retention, pseudomembrane penetration, and healing regulation, offering a paradigm for the treatment of mucosal diseases.


  • Circularization of Aptamer Nanomedicine Improves Nuclease Resistance, Targeted Recognition, and Transdermal Effect for Topical Psoriasis Therapy

    by Zhe Liu, Yao Xu, Yuyan Qian, Yu Fan, Zhen Fan, Jianzhong Du, Yong Hu

    Inhibiting excessive hyperproliferation and inflammatory responses of keratinocytes are two primary tasks against psoriasis, which, however, have not been well integrated by the current available nanomedicines. Herein, we develop a nucleic acid nanomedicine through coassembly of circular aptamers and gold nanoclusters via electrostatic interactions for psoriasis therapy. After topical application, this nanomedicine bearing vascular endothelial growth factor (VEGF) and tumor necrosis factor alpha (TNF-α) aptamers crosses the stratum corneum and enters the deep layers of psoriatic site, from which it specifically inhibits VEGF-mediated keratinocyte proliferation and TNF-α-mediated inflammatory responses simultaneously. More importantly, the circular aptamers further promote the nuclease resistance, targeted recognition, and transdermal effect of the nanomedicine, as compared to their linear counterparts. These improved synergistic actions effectively prevent and cure psoriasis of mice induced by imiquimod. It is anticipated that this study provides a general strategy for targeted regulation of intricate pathological microenvironments beyond psoriasis.


  • Circularized Supramolecular Spherical Nucleic Acids Alleviates Liver Fibrosis through Blocking Upstream Activation and Reversing Activation State of Hepatic Stellate Cells

    by Yao Xu, Yu Fan, Zinan Zhao, Wei Hu, Yuyan Qian, Yong Hu

    Inhibition of hepatic stellate cell (HSC) activation and reversal of its activation state represent two distinct yet complementary strategies in antifibrotic therapy. While synergy of those two strategies is anticipated to improve the therapeutic outcomes, synergism through nanomedicine remains elusive. Herein, we report a circular spherical nucleic acid (cSNA) with a supramolecular core comprising collagenase I and ML-290 and a surface attached with circular PDGF-BB aptamer instead of the stereotypical linear counterpart. Unlike conventional inert SNA, this cSNA core dissociates in response to elevated ROS levels in the fibrotic liver so that collagenase I is released to disrupt the collagen barrier to promote the penetration of ensuing nanoparticles. Of significant importance is that the PDGF-BB aptamer after circularization exhibits enhanced nuclease resistance and improved molecular recognition, thereby demonstrating superior capability in blocking HSC activation mediated by PDGF-BB/PDGFR-β signaling. Meanwhile, relaxin family peptide receptor 1 (RXFP1) agonist ML-290 initially transforms pro-fibrogenic macrophages into pro-resolution macrophages by activating RXFP1 signaling, facilitating the secretion of pro-resolution factors for the reversal of the activated state of HSCs. This work thus presents a proof-of-concept demonstration of a supramolecular SNA that undergoes structural and functional refinements, enabling concurrent upstream etiological blockade and downstream pathological restoration in liver fibrosis.


  • Coordination of Functional Oligonucleotides Yields a Versatile Nanocomposite Microneedle Patch to Facilitate Local Wound Microenvironment Remodeling via Systemic Hyperglycemia Regulation

    by Yuyan Qian, Beibei Zhang, Yao Xu, Junhao Liang, Xingsen Yang, Yifan Gu, Zhen Fan, Dong Li, Yong Hu

    Hyperglycemia exacerbates bacterial infections, disrupts angiogenesis, and perpetuates chronic inflammation in the wound. Therefore, the effective management of diabetic wounds necessitates a synergistic approach that integrates local wound microenvironment remodeling with systemic hyperglycemia regulation. Herein, an unprecedented hierarchical cobalt pyrophosphate/DNA (Co2PPi/DNA) nanocomposite is reported for this purpose. Unlike the stereotypical assembly of either enzymatically polymerized ultralong nucleic acids with Mg2PPi nanosheets at low assembly ratios or commercial homo‐oligonucleotides devoid of biofunctionalities in the presence of metal ions, this study represents the first demonstration on coordination‐driven high‐efficiency co‐assembly of biofunctional hetero‐oligonucleotides and non‐Mg2PPi nanosheets, specifically glucagon receptor (GCGR) aptamer and Co2PPi nanosheets. To improve the bioavailability of nanocomposites, a dissolvable microneedle patch is applied for their wound delivery. Thereafter, nanocomposites dissociate in the wound for sustained release of Co2+ ions and GCGR aptamer, from which Co2+ ions eliminate colonized bacteria and promote angiogenesis through stabilizing HIF‐1α, meanwhile, aptamer after circulating to liver reduces blood glucose levels by binding to hepatocyte GCGR. Importantly, this hypoglycemic effect promotes antibacterial and pro‐angiogenic efficacy and alleviates the inflammatory responses. This work highlights significant advancements in the coordination of biofunctional hetero‐oligonucleotides into a versatile nanocomposite architecture to remodel local pathological microenvironment facilitated by systemic factor regulation.